The US Food and Drug Administration's perspective on the new antidepressant vortioxetine

J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2014 - psychiatrist.com
Objective: This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.

J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2015 - europepmc.org
Objective This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine

J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …

on the New Antidepressant Vortioxetine

J Zhang, MV Mathis, JW Sellers, G Kordzakhia… - J Clin …, 2015 - psychiatrist.com
Objective: This article summarizes the US Food and Drug Administration's (FDA's) review of
the New Drug Application for vortioxetine, especially the clinical efficacy and safety data. It …

[引用][C] The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine

J Zhang, MV Mathis, JW Sellers… - The Journal of …, 2014 - Physicians Postgraduate Press, Inc.

[引用][C] on the New Antidepressant Vortioxetine

J Zhang, MV Mathis, JW Sellers, G Kordzakhia… - J Clin Psychiatry, 2015